Explore our enterprise-grade product inventory. Fully customizable for private label distribution, optimized for bio-availability, and manufactured under strict international quality control standards.
Navigating the shifts in metabolic and cardiovascular wellness: How enterprise buyers, pharmaceutical brands, and retail giants optimize lipid health supply chains.
The global market for cardiovascular health and lipid regulation supplements is undergoing unprecedented growth. Hyperlipidemia, characterized by elevated low-density lipoprotein cholesterol (LDL-C), triglycerides, and total cholesterol, remains a primary risk factor for Atherosclerotic Cardiovascular Disease (ASCVD). Consequently, global brand owners, healthcare networks, and dietary supplement distributors are shifting focus toward scientifically validated, non-prescription cholesterol management alternatives.
Modern procurement directors require OEM/ODM partners capable of delivering standardized bioactive ingredients—such as fermented Red Yeast Rice (Monacolin K), Phytosterols, Citrus Bergamot polyphenols, Omega-3 ethyl esters, and Niacin complexes—backed by robust clinical trial dossiers and rigorous batch safety certifications.
One of the primary challenges in sourcing lipid management nutraceuticals is maintaining regulatory compliance across divergent market territories. For instance, the European Food Safety Authority (EFSA) enforces strict limits on Monacolin K dosages and mandate non-detectable levels of mycotoxins like Citrinin.
Our OEM/ODM manufacturing facility utilizes proprietary dual-stage fermentation and advanced ultrafiltration techniques. This process guarantees maximum therapeutic efficacy while keeping Citrinin residues below 5 ppb (parts per billion), fully satisfying EFSA, US FDA NDI, and global health authority thresholds.
A global leader in pharmaceutical R&D, active ingredient production, and custom ODM/OEM formulation manufacturing.
Xian QLU Health Pharmaceutical Technology Co., Ltd. is dedicated to the development, production, and international marketing of high-purity pharmaceutical products, functional food ingredients, essential vitamins, organic intermediates, and specialized fine chemicals.
Headquartered in Xiamen / Xi'an, China, QLU Health operates 3 state-of-the-art production bases located in Shandong, Zhejiang, and Hebei. These manufacturing hubs hold multi-year operational experience in the chemical synthesis and bio-fermentation of APIs, multi-vitamin compounds, and therapeutic dietary ingredients.
Our production facilities maintain international quality accreditations, including GMP, ISO 9001/22000, FAMI-QS, KOSHER, and HALAL certifications. We exercise complete, vertically integrated control over product development, custom molecule design, and large-scale manufacturing using cutting-edge reaction vessels, automated purification lines, and advanced analytical testing centers.
In the fast-evolving pharmaceutical and nutraceutical domain, QLU’s organizational spirit is defined by structural flexibility, continuous scientific innovation, and client-centric adaptability. We actively incorporate emerging biological extraction methods, modern green chemistry protocols, and automated manufacturing systems to address the shifting requirements of global health brand owners, pharmacy chains, and clinical entities.
With core competencies spanning human pharmaceuticals, animal health, and dietary supplements, QLU Health (Richer Pharma) has established extensive commercial distribution networks worldwide. We operate Strategic Marketing Hubs and Regional Operational Offices in Mumbai, India, and Dubai, UAE, ensuring seamless logistics, local regulatory support, and rapid procurement response times for our international clients.
Initiated targeted R&D and specialized distribution of primary pharmaceutical products, high-grade food ingredients, and active vitamin complexes.
Expanded global trade operations, actively engaging in international marketing of APIs, nutritional raw materials, feed additives, and organic intermediates.
Integrated large-scale industrial manufacturing by acquiring and upgrading 3 specialized production bases across Shandong, Zhejiang, and Hebei provinces.
Fully devoted to comprehensive development, end-to-end OEM/ODM contract manufacturing, and international export of custom APIs, fine chemicals, and finished dosage formulations.
Empowering global pharmaceutical and nutritional brands with scalable infrastructure and uncompromised quality assurance.
Our formulation R&D team targets multi-action metabolic pathways to deliver superior clinical efficiency in cholesterol reduction.
Utilizing standardized bioactive Monacolin K extracted from precision-fermented Monascus purpureus, our formulations naturally inhibit HMG-CoA reductase—the rate-limiting enzyme in hepatic cholesterol synthesis—effectively reducing circulating LDL levels.
Integrating non-GMO Phytosterols (Plant Sterols & Stanols) that competitively displace dietary and biliary cholesterol from micellar structure in the intestinal lumen, thereby limiting systemic absorption into bloodstream capillary networks.
Incorporating bioactive polyphenols from Citrus Bergamot (BPF) and Policosanol to activate AMP-activated protein kinase (AMPK), promoting high-density lipoprotein (HDL) reverse cholesterol transport while suppressing VLDL oxidation.
We offer full-spectrum custom dosage development tailored to brand specifications, target demographics, and regulatory jurisdictions:
| Dosage Form | Active Ingredient Compatibility | Key Bio-Availability Advantage | Target Regulatory Market |
|---|---|---|---|
| Liquid-Filled Hard Capsules | Phytosterols, CoQ10, Omega-3 Ethyl Esters | Rapid gastric dispersion; protects hydrophobic actives from oxidation. | USA, European Union, APAC |
| Enteric-Coated Softgels | Red Yeast Rice Extract, Citrus Bergamot BPF | Bypasses stomach acid to prevent digestive breakdown; zero reflux. | Global Medical & Retail Channels |
| Bilayer / Extended-Release Tablets | Niacin (Inositol Hexanicotinate), Policosanol | Provides continuous 12-hour sustained release; prevents flush effect. | Pharmaceutical & Clinical Brands |
| Pectin/Gelatin Functional Gummies | Plant Sterols, Vitamin D3, Black Seed Oil | High consumer compliance; customizable natural fruit flavor profiles. | Mass Market & E-Commerce Retail |
Navigating international health regulations with turnkey regulatory dossiers and rigorous quality control protocols.
Full compliance with US FDA 21 CFR Part 111 (Dietary Supplements) and Part 211 (cGMP APIs). Complete assistance with New Dietary Ingredient (NDI) filings, GRAS notifications, and Master File documentation.
Strict adherence to Regulation (EU) 2022/860 regarding Monacolins from Red Yeast Rice. Rigorous analytical validation ensuring Citrinin-free formulations and complete toxicological safety profiles.
Dedicated production lines certified Halal (JAKIM/MUI recognized) and Kosher. Strategic regional support provided through our Mumbai and Dubai distribution and service hubs.
Every commercial batch produced across our Shandong, Zhejiang, and Hebei facilities undergoes comprehensive laboratory testing before release. Our quality testing protocols utilize:
In addition to lipid management formulations, QLU Health manufactures high-purity APIs, veterinary medicines, wellness gummies, and specialized healthcare solutions.
Clear answers for B2B procurement managers, regulatory officers, and private label brand partners.
QLU Health
